Yale Hematology Oncology Fellows
@YaleHemOnc
Followers
2K
Following
3K
Media
180
Statuses
751
Official Twitter of the @Yale Hematology & Oncology Fellowship Program @YaleHematology | @YaleCancer | @SmilowCancer
New Haven, CT
Joined June 2020
RT @oncodaily: Amer Zeidan Congratulates New Class of Hematology-Oncology Fellows at Yale Cancer Center.@Dr_AmerZeidan @YaleCancer @YaleHem….
0
2
0
Congrats to our new fellows for finishing their first month with (literally) flying colors!
0
1
40
Congratulations to the graduates, class of 2025! You were brilliant. You were kind. You were compelling. You were inspiring. And as you go off to different parts of the country, on new and bold adventures, know that we are so proud! And know that this will always be home. 👏🏾👏🏼💙
0
6
56
The first year fellows are almost here, and we are so thrilled. Welcome! We were feeling incomplete without you. And congratulations to our senior fellows on finishing the year strong. The future of hematology and oncology is oh so bright! ✨️
0
9
58
RT @AyeshaButtMD: Super high yield lecture on sickle cell acute pain crises for IM residents, by THE Dr Jennifer Afranie-Sakyi 🙌🙌. @YaleHem….
0
1
0
What an incredible opportunity the Dixwell Community House provided chief @KwarambaT90 to participate in the "Walk with a Doc" event as part of the Men's Health Expo and walk. Between encouraging cancer screening, mental health and learning about the community, it was a gift.
0
1
6
0
4
29
RT @YaleCancer: .@ThejalSrikumar and @KwarambaT90 highlight a new format @YaleHemOnc fellowship for teaching pharmacology using case-based,….
0
2
0
RT @YaleCancer: .@CostaPhilippos shared results of a phase 2 trial using Olaparib in IDH1 and IDH2 mutant #chondrosarcomas. Olaparib did no….
0
5
0
RT @YaleCancer: Join us LIVE tonight at 6pm for this Spring's final #SmilowShares with Primary Care on #ColorectalCancer. Presenters includ….
0
1
0
RT @YaleCancer: Research led by @ncasasanta @YaleBreast assessed the TP53 Y220C mutation landscape in clinically advanced #breastcancer (CA….
0
4
0
0
3
0
Look at this legend, literally juggling two posters at the same time on "A Phase II Study of Olaparib in IDH1 and IDH2 Mutant Chondrosarcomas and Other Solid tumors" and "A Phase 2 Study of Olaparib and Ceralasertib in IDH mutant Solid Tumors" at #ASCO25. Dr. Costa, a legend.
1
4
21
Dr. Yochum will always impress! He presented this morning on "Assessment of time- to- treatment- failure (TTF) as a surrogate endpoint for overall survival (OS) to immune checkpoint inhibitor (ICI) regimens in metastatic RCC: Findings from an IMDC analysis" at #ASCO25. In awe.
1
2
27
This morning Dr. Casasanta was commanding her audience presenting on "TP53 genomic alterations including targetable TP53 Y220C mutation in clinically advanced breast cancer" at #ASCO25. Former fellow and now breast attending Dr. Du is clearly impressed. Incredible job Nicole!
1
5
18
RT @YaleCancer: This afternoon at 1:30pm CDT #ASCO25, @JuanJVelasco, @KwarambaT90, and @CostaPhilippos share new research advances from Yal….
0
3
0
RT @YaleCancer: .@curtperrymdphd presents #ASCO25 on a novel RNA sequencing approach to identify a resistance mechanism enriched in neuroen….
0
5
0